Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
View Older Stories
-
Amazon.com (AMZN) PT Raised to $350 at TD Cowen
-
Braveheart Bio targets up to $318.8M in US IPO
-
TD Cowen Upgrades Trican Well Service Ltd. (TCW:CN) (TOLWF) to Buy
-
Unilever plc (ULVR:LN) (UL) PT Raised to GBP57 at TD Cowen
-
Coca-Cola (KO) PT Raised to $100 at TD Cowen
-
Seagate Technology (STX) PT Raised to $1,000 at TD Cowen
-
TD Cowen on Parsons Corp. (PSN): 'C26 sales/EBITDA guidance is now 5%/19% below Street'
-
Synlogic and Caldera Therapeutics agree to all-stock merger
-
TD Cowen Downgrades Caesars Entertainment (CZR) to Hold
-
TD Cowen Starts Opus Genetics (IRD) at Buy
-
Humana seen posting stronger Q2 as Medicare Advantage margins improve
-
Rimini Street (RMNI) PT Raised to $5 at TD Cowen
-
South State (SSB) PT Raised to $120 at TD Cowen
-
TFI International (TFII) PT Raised to $158 at TD Cowen
-
Procore Technologies, Inc (PCOR) PT Lowered to $60 at TD Cowen
-
Baker Hughes (BKR) PT Raised to $78 at TD Cowen
-
TD Cowen Starts Loblaw Companies Ltd. (L:CN) (LBLCF) at Buy
-
TD Cowen Downgrades RXO, Inc. (RXO) to Sell
-
TD Cowen Downgrades Intuit (INTU) to Hold
-
TD Cowen Starts Yarrow Bioscience (YARW) at Buy
-
Huron adds Dr. L. Thomas Richards to its board of directors
-
TD Cowen reports short interest changes in life science stocks
-
TD Cowen on MapLight Therapeutics (MPLT): 'tolerability looked favorable'
-
Charter Communications (CHTR) PT Lowered to $380 at TD Cowen
-
TD Cowen Downgrades Forte Biosciences Inc. (FBRX) to Hold
-
SAP AG (SAP) PT Lowered to $205 at TD Cowen
-
T-Mobile (TMUS) PT Lowered to $260 at TD Cowen
-
Union Pacific (UNP) PT Raised to $325 at TD Cowen
-
TD Cowen Reiterates Hold Rating on Intel (INTC)
-
Medpace (MEDP) PT Raised to $492 at TD Cowen
-
The Blackstone Group (BX) PT Raised to $145 at TD Cowen as 'The Bull Case Emerges'
-
TD Cowen Upgrades Digital Realty Trust (DLR) to Buy
-
TD Cowen Reiterates Hold Rating on Plug Power (PLUG)
-
Lilly to file for next-gen obesity drug approval in early 2027
-
Scancell to acquire Neuphoria in all-share deal, pursue Nasdaq listing
-
TD Cowen Downgrades BioLife Solutions (BLFS) to Hold
-
TD Cowen on Affiliated Managers Group (AMG): 'Selloff Seems Overdone'
-
SharkNinja (SN) PT Raised to $160; TD Cowen: 'We view any pullback in the stock as an opportunity'
-
'Top Pick' General Motors (GM) PT Raised to $132 at TD Cowen
-
Dynatrace Inc. (DT) PT Raised to $50 at TD Cowen
-
Danaher (DHR) PT Lowered to $236 at TD Cowen; 'BP Timing Issue Creates Better Entry'
-
Datadog (DDOG) PT Raised to $300; TD Cowen 'Expecting Strong Beat & Raise'
-
TD Cowen Reiterates Buy Rating on Axon Enterprise (AXON); Sees Strong Beat and Raise
-
Mentari Therapeutics raises $200M in private placement tied to INM merger
-
TD Cowen Upgrades Genmab A/S (GMAB) to Buy
-
TD Cowen Resumes Altius Minerals Corp (ALS:CN) (ATUSF) at Hold
-
Halliburton (HAL) PT Lowered to $47 at TD Cowen
-
e.l.f. Beauty (ELF) PT Raised to $85 at TD Cowen
-
Estee Lauder (EL) PT Raised to $90 at TD Cowen
-
TD Cowen on ULTA Beauty (ULTA): 'Attractive Valuation as Execution Continues to Improve'

